Continue Reading
Full article on Unknown
Lifecore Biomedical to be Added to Nasdaq Biotech Index
Market Intelligence Analysis
AI-Powered
Why This Matters
Lifecore Biomedical, a contract development and manufacturing organization, has been selected to be added to the Nasdaq Biotech Index, effective prior to market open on Monday, December 18, 2025.
Market Impact
Market impact analysis based on bullish sentiment with 78% confidence.
Sentiment
Bullish
AI Confidence
78%
Article Context
Note: This is a brief excerpt for context. Click below to read the full article on the original source.
CHASKA, Minn., Dec. 18, 2025 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: LFCR) (“Lifecore”), a fully integrated contract development and manufacturing organization (“CDMO”), today announced that it has been notified by Nasdaq that the company’s stock is expected to be added to the Nasdaq Biotech Index (NASDAQ: NBI) as part of the annual reconstitution of the 2025 Nasdaq indexes. Lifecore’s inclusion in the Nasdaq Biotech Index will be effective prior to market open on Monday, December
Original article published by
Unknown
on December 18, 2025.
Analysis and insights provided by AnalystMarkets AI.
Analysis and insights provided by AnalystMarkets AI.